Status:
COMPLETED
Assessment of New Enhanced Ostomy Device in Real-life Settings in Subjects Having a Stoma
Lead Sponsor:
Coloplast A/S
Conditions:
Ileostomy - Stoma
Colostomy Stoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study investigates the performance of a new adhesive with regard to the skin condition
Eligibility Criteria
Inclusion
- Have given written informed consent
- Have an ileostomy or a colostomy with liquid\* output (as their usual output)
- Be at least 18 years of age and have full legal capacity
- Have had their stoma for at least three months
- Be able to use products with max cut size 45 mm
- Have self-reported problems with leakage\*\* (three times within 14 days)
- Handle the Clinical App, test product and comparator product themselves
- Use a flat SenSura® Mio or a flat SenSura® with standard adhesive as their current product
- Minimum change of baseplate at least once every 3rd day
- Are willing and suitable (determined by investigator/study nurse) to use the test product and comparator without using a paste/mouldable ring during the investigation
- Are willing and suitable (determined by investigator/study nurse) to use a 1-piece product during the investigation
Exclusion
- Are currently receiving or have within the past two months received radio-and/or chemotherapy (low doses chemotherapy are allowed for other indications than cancer, e.g. below 15 mg methotrexate for rheumatoid arthritis)
- Are currently receiving or have within the past month received topical steroid treatment in the peristomal skin area (e.g. lotion or spray) or systemic treatment\* (e.g. injection or tablets).
- Get a positive result of a pregnancy test for women of childbearing age/fertile (\*\*clarified in section 6.3.2)
- Are breast feeding
- Are participating in other interventional clinical investigations or have previously participated in this investigation
- Exception:
- Participation in other Coloplast in-house clinical investigations is accepted under the circumstances that the subject has paused the activities in the investigation and are otherwise complying with the inclusion and exclusion criteria of this (CP300) protocol.
- \- Have known hypersensitivity towards any of the products used in the investigation
Key Trial Info
Start Date :
November 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 6 2019
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT03770078
Start Date
November 12 2018
End Date
March 6 2019
Last Update
April 1 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
CCBR Aalborg
Aalborg, Denmark, 9000
2
Coloplast
Humlebæk, Denmark, 3050
3
CCBR Vejle
Vejle, Denmark, 7100
4
KTA Prim Stockholm
Stockholm, Sweden, 11361